Genetic screening in two Iranian families with early-onset Alzheimer's disease identified a novel PSEN1 mutation

Neurobiol Aging. 2018 Feb:62:244.e15-244.e17. doi: 10.1016/j.neurobiolaging.2017.10.011. Epub 2017 Oct 23.

Abstract

A subset of early-onset Alzheimer's disease is inherited as an autosomal-dominant trait and is associated with mutations in the genes encoding β-amyloid precursor protein, presenilin 1, or presenilin 2. In this study, we identified 2 PSEN1 mutations (1 novel and 1 known) in 2 unrelated Iranian families with autosomal-dominant Alzheimer's disease. The disease progressed rapidly with a mean age at onset of 33 and 42 years and an age at death ranging from 43 to 48 years.

Keywords: Early-onset Alzheimer's disease; PSEN1 mutation; Rapid disease progression.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / genetics*
  • Disease Progression
  • Female
  • Genes, Dominant / genetics
  • Genetic Association Studies*
  • Genetic Testing*
  • Humans
  • Iran
  • Male
  • Middle Aged
  • Mutation*
  • Presenilin-1 / genetics*

Substances

  • PSEN1 protein, human
  • Presenilin-1